Life Sciences Tools & Services
Price
$409.38
-1.01%Market Cap
$37.34B
Day High
$412.10
Day Low
$402.83
Waters Corporation’s Q2 FY2026 revenue more than doubled, but surging expenses resulted in a net loss and significant balance sheet expansion from a likely acquisition.
Key risk: High Expense Growth May Erode Profitability
SG&A and R&D expenses grew at triple-digit rates, far exceeding revenue growth, leading to an operating loss. If these expenses continue to outpace revenue, the company may face sustained losses.
Other Life Sciences Tools & Services companies